CIB&RC registration is the mandatory central approval every insecticide, pesticide, bio-pesticide, herbicide, fungicide, rodenticide, PGR and agricultural antibiotic must hold before it is imported, manufactured, sold or used in India. It is granted by the Registration Committee under Section 9 of the Insecticides Act, 1968, after the Committee is satisfied on the product's chemistry, bio-efficacy, toxicology and packaging. The correct route — 9(3B) provisional, 9(3) new, or 9(4) me-too — decides the data, cost and time.
What CIB&RC registration is, in one paragraph
The Central Insecticides Board & Registration Committee are two bodies created by the Insecticides Act, 1968. The Board advises government on technical matters; the Registration Committee, working from the Secretariat at the Directorate of Plant Protection, Quarantine & Storage in Faridabad, is the body that actually registers products under Section 9. Until a product holds a certificate of registration in Form II, it cannot lawfully be imported, manufactured, formulated, sold, stocked or even offered for sale anywhere in India. Registration is the gate; everything commercial sits on the far side of it.
Who must register — and who applies
Registration is mandatory for Indian manufacturers of technical-grade actives and of formulations, for importers of technicals or finished formulations, for formulators, for anyone introducing a new active ingredient, and for me-too applicants relying on an already-registered product. A foreign manufacturer cannot register in its own name; it must act through an Indian subsidiary, joint venture or an authorised Indian agent who applies in its own name and carries the statutory obligations. Getting the applicant entity right at the start avoids re-filing later.
The three routes under Section 9 — and why the choice governs everything
Almost every costly mistake in Indian pesticide registration is a route chosen wrongly at the beginning. The three routes are not interchangeable, and data generated for one rarely transfers cleanly to another.
| Route | When it applies | What you get | Data burden |
|---|---|---|---|
| 9(3B) — Provisional | The molecule is already registered in India and you want to begin activity while the full file is evaluated | Provisional registration, ordinarily up to two years, subject to conditions | Moderate; time-boxed |
| 9(3) — New | The active, source or use pattern is new to India — a first registration or a new label claim | Full registration on a complete, independently generated data package | Highest; multi-year |
| 9(4) — Me-too | An identical product is already registered by another applicant and you want the same product on the same terms | Me-too registration built largely on comparative chemistry | Lightest |
Within each section you then pick a category: Technical Import (TI), Formulation Import (FI), Technical Indigenous Manufacture (TIM) or Formulation Indigenous Manufacture (FIM). Section plus category together fix the exact data requirement. This is the single most consequential decision in the whole process, which is why a competent consultant settles it before a rupee is spent on studies.
The data package the Committee actually examines
Depending on route and category, a dossier is assembled from some or all of the following. The Committee reads for internal consistency as much as for completeness — a source named in the chemistry section must match the source in every annexure.
- Product chemistry: five-batch analysis, identity and composition, manufacturing process and flow chart, specifications of the technical and the formulation, impurity profile.
- Physico-chemical properties of the technical and formulation, and storage stability / accelerated shelf-life data.
- Bio-efficacy trials in Indian agro-climatic conditions, at approved institutions, matching the exact crop-pest-dose claim on the label.
- Toxicology (acute, sub-chronic, chronic as required) and ecotoxicology covering non-target organisms.
- Residue and, where relevant, operator-exposure data.
- Packaging, label and leaflet in the prescribed format, with statutory declarations and no unapproved claims.
How a file moves: from feasibility to Form II
- Feasibility & data-gap analysis. Check the active against the Schedule, the register of approved products and the banned/restricted lists; fix the section and category; produce a written comparison of data held versus data required, costed and dated.
- Study placement. Commission only the studies the gap analysis identifies, at recognised laboratories and institutions, tracked against protocol and trial season.
- Dossier compilation & filing. Application in the prescribed form with every annexure consistent, filed with the Secretariat.
- Technical evaluation & queries. Expert evaluation, then deficiency letters that must be answered with data, not explanation, and tracked against the Committee's agenda so the case is not quietly carried over.
- Grant & post-approval. Certificate in Form II, followed by state manufacturing and sale licences before any commercial activity begins.
Realistic timelines and cost drivers
Anyone quoting a single number is guessing. As planning ranges: a clean 9(4) me-too file commonly moves in about six to twelve months; a 9(3B) provisional in roughly six to nine months; a 9(3) new molecule in three to five years, of which the great majority is data generation, not paperwork. Cost differs by orders of magnitude for the same reason: a me-too is largely government fees plus documentation, whereas a new molecule carries toxicology, ecotoxicology, residue and multi-season bio-efficacy studies that can run into crores. A trustworthy quote separates government fees, study costs and consultancy fees so you can see where the money goes.
After the certificate: what keeps a registration alive
Registration is not a one-time event. Shelf-life enhancement, packaging changes, label-claim additions, source changes, and endorsements or transfers on a change of company name or address are all handled through applications to the Registration Committee. Central registration must also be paired with state manufacturing and sale/stock/distribution licences before selling. Treating the certificate as the finish line is how companies end up unable to sell a product they have lawfully registered.
Where files actually fail
In practice, rejections and long delays cluster around a handful of avoidable causes: the wrong section or category chosen at the outset; chemistry and annexures that disagree on source or composition; bio-efficacy that does not match the label claim or was run outside approved protocols; labels carrying unapproved claims; and deficiency letters answered with argument instead of the study the Committee asked for. Every one of these is preventable with an honest gap analysis before filing.
How Pransh can help. We are CIB&RC registration consultants based in Faridabad, minutes from the Secretariat. Send us your active ingredient, formulation and intended market and we will confirm the applicable section and category, tell you what data is missing, and give you a written, costed data-gap analysis — before you spend on studies. Call +91 98717 89630 or email info@cibconsultant.com.